FindTrial
Sign In

Mode of Administration: oral

5 trials

Sponsors

PNB Vesper Life Science Pvt Ltd, Intas Pharmaceuticals Limited, Intas Pharmaceuticals Ltd, Hetero Labs Limited

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsHealth Condition 1: M069- Rheumatoid arthritis, unspecified

Phase 1

A Study of PNB-001 in Healthy, Adult, Human Male Subjects Under Fasting Conditions
Active, not recruitingCTRI/2018/08/015297
PNB Vesper Life Science Pvt Ltd
Target: 42Updated: 2021-11-24
A PHASE I STUDY OF HRF-4467, A NEW ANTI-HIV DRUG, TO EVALUATE THE SAFETY AND DRUG LEVELS IN BLOOD (PK), WHILE FASTING AND FED CONDITIONS, IN HEALTHY MALE VOLUNTEERS
Active, not recruitingCTRI/2019/02/017597
Hetero Labs Limited
Target: 48Updated: 2021-11-24

Phase 2

A study of Metformin with / without Administration of Thymoquinone in Patients with Diabetes
Active, not recruitingCTRI/2018/11/016334
Intas Pharmaceuticals LtdHealth Condition 1: E119- Type 2 diabetes mellitus without complications
Target: 60Updated: 2021-11-24

Unknown Phase

A Study of Methotrexate Tablets 2.5 mg in Adult Patients with Inflammatory Disorder of many joints and/or Patches of Abnormal Skin
Active, not recruitingCTRI/2018/11/016245
Intas Pharmaceuticals LimitedHealth Condition 1: M069- Rheumatoid arthritis, unspecified
Target: 42Updated: 2021-11-24
A study comparing capecitabine oral granules 500 mg per packet to capecitabine tablets 500 mg in patients with breast cancer or colorectal cancer
Active, not recruitingCTRI/2019/10/021793
Intas Pharmaceuticals LtdHealth Condition 1: C509- Malignant neoplasm of breast of unspecified site
Target: 15Updated: 2021-11-24